Aerospace Expansion Clayens has recently acquired aeronautical assets and launched a dedicated aerospace business unit, signaling a strategic push into high-value aerospace and defense markets. This creates cross-sell opportunities for advanced composite, thermoplastic, and metalloplastic solutions, as well as precision manufacturing capabilities.

CDMO Capabilities With a global one-stop CDMO service initiative and extensive R&D/engineering strength, Clayens is well positioned to attract customers seeking end-to-end development to production. Focus on offering integrated product development, regulatory support, and scalable manufacturing for healthcare, aerospace, and industrial sectors.

Compliance & Quality Recent FDA device compliance issues at a facility highlight the importance of robust quality systems. Emphasize and differentiate through enhanced quality assurance, traceability, and regulatory performance to win customers prioritizing risk mitigation and certification readiness.

Medical & Tracker Innovation Clayens’ ongoing collaboration on integrated medical trackers and NFC tagging positions the company for growth in medical devices and smart components. Target medical OEMs and material suppliers seeking embedded sensing, tracking, and product authentication within polymer and metalloplastic parts.

Global Footprint & Cost Advantage Large yet nimble with a presence across Europe, Africa, and North America and access to low-cost manufacturing options. Position Clayens to win international programs requiring global supply, regional production towers, and optimized total cost of ownership.